Morgan Stanley Finance Issues Buffered Participation Securities Linked to Dual Index Performance

Dual Index Linkage and Worst-Case Performance Mechanism

The securities tie investor returns to the performance of both the Dow Jones Industrial Average and the S&P 500 Index, with a distinctive feature that locks returns to whichever index performs worse over the investment period. This worst-performing underlier approach fundamentally differs from traditional diversified securities strategies. Rather than providing exposure to multiple indices for diversification benefits, the structure explicitly concentrates risk on the underperforming asset, meaning that a significant decline in either index beyond the buffer level will reduce investor returns regardless of how the other index performs.

The filing states that investors should understand the value of the securities depends entirely on the worst performing underlier. If the Dow Jones Industrial Average declines sharply while the S&P 500 rises, investors receive returns based on the declining Dow Jones index performance. This design means the securities function as a bear-sensitive investment structure, disadvantaging investors when either major index experiences weakness. The observation date for determining final levels is set for November 11, 2027, subject to postponement for non-trading days and market disruption events, with the actual maturity date following five business days later on November 16, 2027.

Buffer Protection Level and Downside Loss Mechanics

The securities incorporate an 85% buffer level for each underlying index, theoretically providing investors with protection against losses up to a 15% decline from the initial level. The filing discloses that if the final level of either underlier falls below its buffer level, investors lose 1% for every 1% decline beyond the specified buffer amount. This means that investors retain full principal only if both indices remain above their 85% thresholds at maturity. The buffer amount of 15% represents the cushion before losses begin accumulating dollar-for-dollar with further market declines.

Should the worst performing index decline beyond the 85% buffer level, the payment at maturity becomes significantly less than the stated principal amount. The filing indicates that under these circumstances, the payment could be substantially reduced, subject to a minimum payment at maturity of 15% of stated principal. This minimum payment structure means investors cannot lose more than 85% of their initial investment even in a catastrophic scenario where the worst performing index declines more than 85%, effectively capping maximum loss at that threshold while maintaining downside exposure within that range.

Upside Participation and Contingent Return Structure

Investors receive upside participation only when both underlying indices finish with final levels greater than their respective initial levels on the observation date. The filing specifies a participation rate of 100.50%, meaning investors capture slightly more than the full percentage gain of the worst performing underlier. For example, if the worst performing index rises 10%, investors would receive the stated principal amount plus an upside payment equivalent to 10.05% of principal, assuming both indices remain above their starting levels. This 100.50% participation rate applies only to gains and only when the performance condition is met.

If either index closes at or below its initial level, no upside payment is provided, and investors receive only their stated principal amount, assuming the worst performing underlier remains above the 85% buffer level. This contingent structure creates multiple return scenarios depending on market performance. The filing emphasizes that these securities are designed specifically for investors seeking exposure to the worst performing index among the two and who are willing to forgo current income in exchange for the buffer protection feature, acknowledging the unconventional nature of this investment approach.

Pricing, Valuation, and Cost Transparency

The issue price for each security is $1,000 per security, sold directly to fee-based advisory accounts. The filing discloses an estimated value on the pricing date of approximately $985.20 per security, representing a difference of $14.80 from the issue price. This gap reflects costs associated with issuing, selling, structuring and hedging the securities, which are borne by investors at purchase. The estimated value range specified in the preliminary pricing supplement was within $35.00 of the central estimate, providing a band within which final valuation was expected to fall.

The valuation methodology incorporates both a debt component and a performance-based component linked to the two underlying indices. Morgan Stanley uses its own pricing and valuation models, market inputs, and assumptions regarding the underliers, volatility, interest rates, and secondary market credit spreads to determine the estimated value. The filing states that the original issue price of $1,000 includes all costs of issuance, meaning the effective purchase price net of embedded costs is the $985.20 estimated value figure. This valuation transparency allows investors to understand that approximately $14.80 per security (or potentially up to $35.00 depending on final pricing) represents non-recoverable costs incurred in structuring the product.

Agent Distribution, Commissions, and Advisory Requirements

Morgan Stanley & Co. LLC, an affiliate of Morgan Stanley Finance LLC and a wholly owned subsidiary of Morgan Stanley, serves as the agent for this offering and expects to purchase the securities from the issuer for resale to fee-based advisory accounts. The filing indicates that selected dealers and their financial advisors may receive a structuring fee of up to $6.25 for each security from the agent or its affiliates. Additionally, Morgan Stanley & Co. may pay a third-party data analytics provider a fee of $0.50 for each security sold in the offering, obtained at the request of the third-party dealer involved in the transaction.

Notably, Morgan Stanley & Co. will not receive a sales commission with respect to the securities, a structural detail that distinguishes this offering from traditional commission-based securities sales. The filing also discloses that Morgan Stanley & Co., as an affiliate of the issuer, makes no representations or warranties regarding the use or fitness of the analytics services and specifically disclaims liability relating to such analytics. This dual-role arrangement—where Morgan Stanley functions simultaneously as issuer affiliate, distribution agent, and potential purchaser—creates the conflicts of interest explicitly noted in the preliminary pricing supplement's supplemental information regarding plan of distribution section.

Credit Risk and Guarantee Structure

Although the securities are issued by Morgan Stanley Finance LLC, an affiliate of Morgan Stanley, they are fully and unconditionally guaranteed by Morgan Stanley itself. This guarantee structure means that investors depend on Morgan Stanley's creditworthiness for repayment of both principal and any contingent payments due at maturity. The filing explicitly states that all payments remain subject to Morgan Stanley's credit risk, and if Morgan Stanley defaults on its obligations, investors could lose some or all of their investment. This guarantee provides no additional asset backing beyond Morgan Stanley's general credit standing.

The filing emphasizes that the securities are unsecured obligations with no security interest in any underlying reference assets or access to any collateral. Investors hold only Morgan Stanley's promise to pay, with no recourse to the Dow Jones Industrial Average or S&P 500 Index components themselves. This unsecured nature, combined with the principal-at-risk structure and embedded costs, means investors face dual risks: both the performance risk of the underlying indices and the credit risk of Morgan Stanley as guarantor. The filing notes that these securities are not deposits, savings accounts, or FDIC-insured products, distinguishing them clearly from traditional bank products.

Investment Suitability Profile and Risk Acknowledgment

Morgan Stanley explicitly identifies the targeted investor profile for these securities in the filing. The securities are designed for investors who seek a return based on the worst performing underlier and who are willing to risk their principal and forgo current income in exchange for the buffer feature. The filing states that investors in these securities must be willing to accept the risk of losing a significant portion of their initial investment based on the performance of either underlier. This language indicates that the issuer views these securities as appropriate only for investors with sophisticated understanding of structured products and substantial risk tolerance.

The preliminary pricing supplement emphasizes that the fact that the securities are linked to more than one underlier does not provide diversification benefits but instead means that a decline in either underlier beyond its buffer level will adversely affect returns, even if the other underlier has appreciated or declined less severely. This counterintuitive risk structure—where multiple indices create concentration risk rather than diversification—is highlighted as a core feature investors must comprehend before purchasing. The securities are not suitable for investors seeking capital preservation, current income, or traditional equity or debt exposure.

Index Selection and Market Disruption Provisions

The securities track two of the most widely recognized U.S. equity indices: the Dow Jones Industrial Average, composed of 30 large-capitalization companies, and the S&P 500 Index, comprising 500 large-capitalization companies with broader market representation. The strike date and pricing date are both set for August 11, 2026, establishing the reference levels from which percentage changes are calculated throughout the security's life. The observation date of November 11, 2027 determines the final levels used to calculate maturity payments, subject to postponement for non-trading days and certain market disruption events as defined in the accompanying product supplement and index supplement.

The inclusion of market disruption provisions indicates that Morgan Stanley has anticipated scenarios where standard index closing procedures may not function normally due to market stress, technology failures, or similar events. These provisions allow the observation date to shift if market disruptions prevent normal index determination. The filing references these details in the accompanying index supplement and product supplement, documents that provide comprehensive definitions of market disruption events and procedures for determining postponed observation dates. Investors should review these supplementary documents to understand the specific triggers and mechanics for any observation date adjustments.

Documentation Framework and Regulatory Filing Status

The preliminary pricing supplement was filed with the Securities and Exchange Commission on July 21, 2026, pursuant to Rule 424(b)(2), a provision that allows distribution of preliminary offering documents for securities registered under SEC Form S-3. The offering references underlying registration statement numbers 333-293641 and 333-293641-01, indicating these securities form part of Morgan Stanley Finance LLC's Series A Global Medium-Term Notes program. The preliminary status of the pricing supplement means that final terms, commissions, and estimated values would be subject to modification in the final pricing supplement, which must be delivered to investors before purchase.

The preliminary pricing supplement directs investors to review several accompanying documents: the Product Supplement for Principal at Risk Securities dated April 8, 2026; the Index Supplement dated April 8, 2026; the Tax Supplement dated April 8, 2026; and the Prospectus dated April 8, 2026. These documents collectively establish the comprehensive terms governing the securities, including additional provisions regarding payment calculations, index adjustments, tax treatment, and use of proceeds. The filing states that investors should read the preliminary pricing supplement together with these related documents, as they form an integrated disclosure package required for informed investment decision-making.

Series Classification and CUSIP Identification

The securities are classified as Principal at Risk Securities, a designation indicating that investor principal remains subject to loss based on underlying market performance. This classification distinguishes them from traditional medium-term notes that typically provide principal protection or moderate capital preservation features. The securities will not be listed on any securities exchange, meaning they will trade, if at all, only in over-the-counter or secondary markets through broker-dealers. The absence of exchange listing limits liquidity and pricing transparency compared to publicly listed securities.

Each security has been assigned CUSIP 61781GT76 and ISIN US61781GT768, identifiers used for tracking and settlement in U.S. securities markets. These identifiers ensure that institutional investors, clearinghouses, and regulatory systems can uniquely identify these specific securities within the broader universe of outstanding notes and structured investments. The securities are due November 16, 2027, establishing a defined maturity period of slightly more than 15 months from the August 14, 2026 original issue date, a timeframe considerably shorter than traditional medium-term note offerings.